Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000148

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Dec 18, 2017
Accepted (ET)
Dec 21, 2017 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 19, 2017P3,000$0.0525A24,531,189D
Common StockDec 19, 2017P3,000$0.0515A24,534,189D
Common StockDec 19, 2017P3,000$0.0515A24,537,189D
Common StockDec 19, 2017P3,000$0.0514A24,540,189D
Common StockDec 19, 2017P3,000$0.0513A24,543,189D
Common StockDec 19, 2017P3,000$0.0514A24,546,189D
Common StockDec 19, 2017P3,000$0.05A24,549,189D
Common StockDec 19, 2017P3,000$0.0499A24,552,189D
Common StockDec 19, 2017P3,000$0.05A24,555,189D
Common StockDec 19, 2017P3,000$0.0499A24,558,189D
Common StockDec 19, 2017P3,000$0.0499A24,561,189D
Common StockDec 19, 2017P3,000$0.048A24,564,189D
Common StockDec 19, 2017P2,000$0.048A24,566,189D
Common StockDec 19, 2017P2,000$0.048A24,568,189D
Common StockDec 19, 2017P2,000$0.048A24,570,189D
Common StockDec 19, 2017P2,000$0.048A24,572,189D
Common StockDec 19, 2017P2,000$0.048A24,574,189D
Common StockDec 19, 2017P2,000$0.05A24,576,189D
Common StockDec 20, 2017P2,000$0.0499A24,578,189D
Common StockDec 20, 2017P2,000$0.0499A24,580,189D
Common StockDec 20, 2017P2,000$0.0499A24,582,189D
Common StockDec 20, 2017P2,000$0.0499A24,584,189D
Common StockDec 20, 2017P2,000$0.0496A24,586,189D
Common StockDec 20, 2017P2,000$0.0499A24,588,189D
Common StockDec 20, 2017P2,000$0.0499A24,590,189D
Common StockDec 20, 2017P2,000$0.0508A24,592,189D

Table II — derivative securities

No Table II lines on this filing.